EA201490030A1 - Соединения, ингибирующие металлоферменты - Google Patents

Соединения, ингибирующие металлоферменты

Info

Publication number
EA201490030A1
EA201490030A1 EA201490030A EA201490030A EA201490030A1 EA 201490030 A1 EA201490030 A1 EA 201490030A1 EA 201490030 A EA201490030 A EA 201490030A EA 201490030 A EA201490030 A EA 201490030A EA 201490030 A1 EA201490030 A1 EA 201490030A1
Authority
EA
Eurasian Patent Office
Prior art keywords
inhibiting compounds
enzyme inhibiting
metallic
metallic enzyme
metalloenzymes
Prior art date
Application number
EA201490030A
Other languages
English (en)
Other versions
EA024789B1 (ru
Inventor
Уиллиам Дж. Хекстра
Кристофер М. Йейтс
Роберт Дж. Шотцингер
Майкл Лосо
Захари А. Бухан
Майкл Салленбергер
Original Assignee
Вайамет Фармасьютикалс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Вайамет Фармасьютикалс, Инк. filed Critical Вайамет Фармасьютикалс, Инк.
Publication of EA201490030A1 publication Critical patent/EA201490030A1/ru
Publication of EA024789B1 publication Critical patent/EA024789B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/64—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
    • A01N43/647—Triazoles; Hydrogenated triazoles
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/64—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
    • A01N43/647—Triazoles; Hydrogenated triazoles
    • A01N43/653—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/713—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with four or more nitrogen atoms as the only ring hetero atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/74—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,3
    • A01N43/78—1,3-Thiazoles; Hydrogenated 1,3-thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)

Abstract

Настоящее изобретение описывает соединения, имеющие активность, модулирующую металлоферменты, и способы лечения заболеваний, нарушений или их симптомов, опосредованных такими металлоферментами.
EA201490030A 2011-06-19 2012-06-19 Соединения, ингибирующие металлоферменты EA024789B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161498570P 2011-06-19 2011-06-19
US201261611897P 2012-03-16 2012-03-16
PCT/US2012/043147 WO2012177638A1 (en) 2011-06-19 2012-06-19 Metalloenzyme inhibitor compounds

Publications (2)

Publication Number Publication Date
EA201490030A1 true EA201490030A1 (ru) 2014-05-30
EA024789B1 EA024789B1 (ru) 2016-10-31

Family

ID=47362418

Family Applications (2)

Application Number Title Priority Date Filing Date
EA201490029A EA025406B1 (ru) 2011-06-19 2012-06-19 Соединения, ингибирующие металлоферменты
EA201490030A EA024789B1 (ru) 2011-06-19 2012-06-19 Соединения, ингибирующие металлоферменты

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EA201490029A EA025406B1 (ru) 2011-06-19 2012-06-19 Соединения, ингибирующие металлоферменты

Country Status (23)

Country Link
US (3) US8748461B2 (ru)
EP (4) EP2721023B1 (ru)
JP (3) JP6247632B2 (ru)
KR (4) KR101912848B1 (ru)
CN (3) CN103781775B (ru)
AR (1) AR088130A1 (ru)
AU (2) AU2012273100B2 (ru)
BR (2) BR122020013521B1 (ru)
CA (2) CA2839691A1 (ru)
CL (1) CL2013003638A1 (ru)
CO (1) CO6930356A2 (ru)
CR (1) CR20140020A (ru)
EA (2) EA025406B1 (ru)
EC (2) ECSP14013152A (ru)
ES (1) ES2700250T3 (ru)
HK (1) HK1198163A1 (ru)
IL (1) IL229965A (ru)
IN (1) IN2014DN00288A (ru)
MX (1) MX351943B (ru)
UA (1) UA114090C2 (ru)
UY (2) UY39413A (ru)
WO (2) WO2012177635A1 (ru)
ZA (1) ZA201400232B (ru)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2721023B1 (en) * 2011-06-19 2018-08-08 Viamet Pharmaceuticals (NC), Inc. Metalloenzyme inhibitor compounds
JP6122846B2 (ja) * 2011-06-19 2017-04-26 ヴィアメット ファーマスーティカルズ，インコーポレイテッド 金属酵素阻害剤化合物
CN103930418A (zh) 2011-06-23 2014-07-16 威尔金制药有限公司 金属酶抑制剂化合物
PL2804858T3 (pl) * 2012-01-20 2020-06-29 Mycovia Pharmaceuticals, Inc. Związki - inhibitory metaloenzymu
WO2014117090A1 (en) * 2013-01-28 2014-07-31 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
WO2014167008A1 (en) 2013-04-12 2014-10-16 Bayer Cropscience Ag Novel triazolinthione derivatives
BR112015025679A8 (pt) 2013-04-12 2020-02-11 Bayer Cropscience Ag novos derivados de triazol
CN105308032B (zh) 2013-04-12 2017-05-24 拜耳作物科学股份公司 新的三唑衍生物
WO2014193974A1 (en) * 2013-05-28 2014-12-04 Viamet Pharmaceuticals, Inc. Fungicidal compositions
JP6386035B2 (ja) * 2013-06-12 2018-09-05 ヴィアメット ファーマスーティカルズ（エヌシー），インコーポレイテッド 金属酵素阻害剤化合物
EP3040073B1 (en) * 2013-08-27 2020-07-08 Sinochem Corporation Applications of substituent benzyloxy group containing ether compounds for preparing antitumor drugs
CN106103424A (zh) * 2014-03-19 2016-11-09 维亚梅特制药公司 2‑(2,4‑二氟苯基)‑1,1‑二氟‑1‑(5‑经取代的吡啶‑2‑基)‑3‑(1h‑四唑‑1‑基)丙烷‑2‑醇和其制备方法
AU2015231275B2 (en) 2014-03-19 2019-03-07 Mycovia Pharmaceuticals, Inc. Antifungal compound process
JP2017509646A (ja) 2014-03-19 2017-04-06 ヴィアメット ファーマスーティカルズ，インコーポレイテッド 抗真菌化合物の調製方法
AU2015231216B2 (en) * 2014-03-19 2019-04-04 Mycovia Pharmaceuticals, Inc. Antifungal compound process
US10399943B2 (en) 2014-03-19 2019-09-03 Mycovia Pharmaceuticals, Inc. Antifungal compound process
CA2942231A1 (en) 2014-03-19 2015-09-24 Viamet Pharmaceuticals, Inc. Antifungal compound process
CA2942968C (en) * 2014-03-19 2022-03-15 William J. Hoekstra Antifungal compound process
MX2016012060A (es) * 2014-03-19 2017-01-19 Viamet Pharmaceuticals Inc 2-(2,4-difluorofenil)-1,1-difluoro-1-(5-sustituido-piridin-2-il)- 3-(1h-tetrazol-1-il)propan-2-oles y procesos para su preparacion.
EP3119749A4 (en) 2014-03-19 2017-12-13 Viamet Pharmaceuticals, Inc. Antifungal compound process
MX369357B (es) 2014-03-19 2019-11-06 Mycovia Pharmaceuticals Inc Procedimiento de compuesto antifungico.
JP2017531636A (ja) 2014-10-02 2017-10-26 バイエル・クロップサイエンス・アクチェンゲゼルシャフト 殺菌剤として有用な新規トリアゾール誘導体
CN107660203A (zh) 2015-04-02 2018-02-02 拜耳作物科学股份公司 作为杀真菌剂的三唑衍生物
EP3702353B1 (en) * 2015-05-18 2023-07-05 Mycovia Pharmaceuticals, Inc. Antifungal compositions
MX2018003280A (es) 2015-09-18 2018-08-16 Vps 3 Inc Proceso de compuesto antifungico.
EP3374350B1 (en) 2015-11-09 2022-01-05 Forge Therapeutics, Inc. Hydroxypyridinone and hydroxypyrimidinone based compounds for treating bacterial infections
WO2017083434A1 (en) 2015-11-09 2017-05-18 Forge Therapeutics, Inc. Pyrone based compounds for treating bacterial infections
CA3005743A1 (en) * 2015-11-17 2017-05-26 Dow Agrosciences Llc 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1h-1,2,4-triazol-1-yl)propyl)pyridin-3-yl)oxy)benzonitrile and processes of preparation
US10513506B2 (en) * 2015-11-17 2019-12-24 Dow Agrosciences Llc 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl)pyridin-3-yl and processes of preparation
WO2017087643A1 (en) * 2015-11-17 2017-05-26 Viamet Pharmaceuticals, Inc. 4-((6-2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1h-1,2,4-triazol-1-yl)propyl)pyridin-3-yl)oxy)benzonitrile and processes of preparation
JP6987070B2 (ja) * 2015-11-17 2021-12-22 コルテバ アグリサイエンス エルエルシー ４−（（６−（２−（２，４−ジフルオロフェニル）−１，１−ジフルオロ−２−オキソエチル）ピリジン−３−イル）オキシ）ベンゾニトリル及び製造方法
MX2019001481A (es) 2016-08-31 2019-05-15 Jiangsu Hengrui Medicine Co Derivado de oxopicolinamida, metodo de preparacion y uso farmaceutico del mismo.
JP2018048090A (ja) * 2016-09-21 2018-03-29 大阪ガスケミカル株式会社 工業用保存剤
US20190276430A1 (en) * 2016-11-18 2019-09-12 Dow Agrosciences Llc 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(5-mercapto-1h-1,2,4-triazol-1-yl)propyl)pyridin-3-yl)oxy)benzonitrile and processes of preparation
EP3541795A4 (en) * 2016-11-18 2020-04-29 Dow AgroSciences LLC PROCESSES FOR THE PREPARATION OF 4 - ((6- (2,4-DIFLUOROPHENYL) -1,1-DIFLUORO-2-HYDROXY-3 (5-MERCAPTO-1H-1,2,4-TRIAZOL-1-YL) PROPYL) PYRIDIN-3-YL) OXY) BENZONITRILE
EP3541798A4 (en) * 2016-11-18 2020-04-29 Dow AgroSciences LLC 4 - ((6- (2- (2,4-DIFLUORPHENYL) -1,1-DIFLUOR-2-HYDROXY-3- (5-MERCAPTO-1H-1,2,4-TRIAZOL-1-YL) PROPYL) PYRIDIN-3-YL) OXY) BENZONITRILE AND METHOD FOR PRODUCING THE SAME
EP3541797A4 (en) * 2016-11-18 2020-04-29 Dow AgroSciences LLC 4 - ((6- (2- (2,4-DIFLUORPHENYL) -1,1-DIFLUOR-2-HYDROXY-3- (5-MERCAPTO-1H
US20190284158A1 (en) * 2016-11-18 2019-09-19 Dow Agrosciences Llc 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(5-mercapto-1h-1,2,4-triazol-1-yl)propyl)pyridin-3-yl)oxy)benzonitrile and processes of preparation
CN109983005A (zh) * 2016-11-18 2019-07-05 美国陶氏益农公司 4-((6-(2-(2,4-二氟苯基)-1,1-二氟-2-羟基-3-(5-巯基-1h-1,2,4-三唑-1-基)丙基)吡啶-3-基)氧基)苄腈及制备方法
US20190284159A1 (en) * 2016-11-18 2019-09-19 Dow Agrosciences Llc 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(5-mercapto-1h-1,2,4-triazol-1-yl)propyl)pyridin-3-yl)oxy)benzonitrile and processes of preparation
CN109983004A (zh) * 2016-11-18 2019-07-05 美国陶氏益农公司 4-((6-(2-(2,4-二氟苯基)-1,1-二氟-2-羟基-3-(5-巯基-1h-1,2,4-三唑-1-基)丙基)吡啶-3-基)氧基)苄腈及制备方法
EP3544432A4 (en) * 2016-11-22 2020-04-22 Dow AgroSciences LLC USE OF A DIFLUOR (2-HYDROXYPROPYL) PYRIDINE COMPOUND AS A FUNGICIDE FOR CONTROLLING LEAF SPOTS OF SUGAR BEET
MA46135B2 (fr) 2016-11-22 2021-01-29 Dow Agrosciences Llc Composés et mélanges fongicides pour la lutte contre les maladies fongiques dans des céréales
WO2018098216A1 (en) * 2016-11-22 2018-05-31 Vps-3, Inc. Use of a difluoro-(2-hydroxypropyl)pyridine compound as a fungicide for control of phytopathogenic fungi of barley
RU2019118627A (ru) * 2016-11-22 2020-12-25 ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи Применение соединения дифтор-(2-гидроксипропил)пиридина в качестве фунгицида для борьбы с фитопатогенным грибком риса
US20190297890A1 (en) * 2016-11-22 2019-10-03 Dow Agrosciences Llc Fungicidal compounds and mixtures for fungal control in cereals
CN109996443A (zh) * 2016-11-22 2019-07-09 美国陶氏益农公司 二氟-(2-羟基丙基)吡啶化合物作为用于防治小麦的植物病原真菌的杀真菌剂的用途
CN110573015A (zh) * 2016-11-22 2019-12-13 美国陶氏益农公司 二氟-(2-羟基丙基)吡啶化合物作为用于防治玉米的植物病原真菌的杀真菌剂的用途
WO2018098218A1 (en) * 2016-11-22 2018-05-31 Vps-3, Inc. Fungicidal compounds and mixtures for fungal control in cereals
CA3044343A1 (en) * 2016-11-22 2018-05-31 Dow Agrosciences Llc Fungicidal compounds and mixtures for fungal control in cereals
UA126065C2 (uk) * 2016-11-22 2022-08-10 Кортева Аґрисайєнс Елелсі Фунгіцидні композиції і суміші для боротьби із грибковими захворюваннями зернових культур
EP3559009B1 (en) 2016-12-22 2021-04-07 Calithera Biosciences, Inc. Compositions and methods for inhibiting arginase activity
WO2018208985A2 (en) 2017-05-10 2018-11-15 Forge Therapeutics, Inc. Antibacterial compounds
WO2019092086A1 (en) 2017-11-13 2019-05-16 Bayer Aktiengesellschaft Tetrazolylpropyl derivatives and their use as fungicides
BR112021005044A2 (pt) 2018-09-20 2021-06-08 Forge Therapeutics, Inc. compostos antibacterianos
WO2021195260A1 (en) 2020-03-25 2021-09-30 Forge Therapeutics, Inc. Lpxc inhibitor and methods of making
TW202144340A (zh) 2020-04-03 2021-12-01 大陸商江蘇恆瑞醫藥股份有限公司 稠合咪唑類衍生物、其製備方法及其在醫藥上的應用
CN113278409B (zh) * 2021-06-22 2022-04-29 西南石油大学 一种高温酸化缓蚀剂
WO2024068656A1 (en) 2022-09-28 2024-04-04 Syngenta Crop Protection Ag Fungicidal compositions
WO2024068655A1 (en) 2022-09-28 2024-04-04 Syngenta Crop Protection Ag Fungicidal compositions

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8304282D0 (en) * 1983-02-16 1983-03-23 Pfizer Ltd Antifungal agents
US4921475A (en) 1983-08-18 1990-05-01 Drug Delivery Systems Inc. Transdermal drug patch with microtubes
US5087240A (en) 1983-08-18 1992-02-11 Drug Delivery Systems Inc. Transdermal drug patch with conductive fibers
US4690942A (en) * 1983-12-20 1987-09-01 Ciba-Geigy Corporation 1-aryl-2-fluoro-2-azolyl alkanones, alkanols, esters, and ethers, composition containing them, and use of them to control phytopathogenic microorganisms
US4738851A (en) 1985-09-27 1988-04-19 University Of Iowa Research Foundation, Inc. Controlled release ophthalmic gel formulation
US5163899A (en) 1987-03-20 1992-11-17 Drug Delivery Systems Inc. Transdermal drug delivery system
US5312325A (en) 1987-05-28 1994-05-17 Drug Delivery Systems Inc Pulsating transdermal drug delivery system
GB8804164D0 (en) 1988-02-23 1988-03-23 Tucker J M Bandage for administering physiologically active compound
US4882150A (en) 1988-06-03 1989-11-21 Kaufman Herbert E Drug delivery system
GB8819308D0 (en) * 1988-08-13 1988-09-14 Pfizer Ltd Triazole antifungal agents
US5008110A (en) 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
US5088977A (en) 1988-12-21 1992-02-18 Drug Delivery Systems Inc. Electrical transdermal drug applicator with counteractor and method of drug delivery
US5521222A (en) 1989-09-28 1996-05-28 Alcon Laboratories, Inc. Topical ophthalmic pharmaceutical vehicles
ATE107176T1 (de) 1989-12-04 1994-07-15 Searle & Co System zur transdermalen albuterol applikation.
US5077033A (en) 1990-08-07 1991-12-31 Mediventures Inc. Ophthalmic drug delivery with thermo-irreversible gels of polxoxyalkylene polymer and ionic polysaccharide
ATE141502T1 (de) 1991-01-15 1996-09-15 Alcon Lab Inc Verwendung von karrageenan in topischen ophthalmologischen zusammensetzungen
GB9121456D0 (en) * 1991-10-10 1991-11-27 Pfizer Ltd Triazole antifungal agents
US5352456A (en) 1991-10-10 1994-10-04 Cygnus Therapeutic Systems Device for administering drug transdermally which provides an initial pulse of drug
EP0617665B1 (en) 1991-12-18 1999-03-31 Minnesota Mining And Manufacturing Company Multilayered barrier structures
ATE132381T1 (de) 1992-01-29 1996-01-15 Voelkl Franz Ski Ballspielschläger, insbesondere tennisschläger
IL114193A (en) 1994-06-20 2000-02-29 Teva Pharma Ophthalmic pharmaceutical compositions based on sodium alginate
ES2094688B1 (es) 1994-08-08 1997-08-01 Cusi Lab Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
IT1283911B1 (it) 1996-02-05 1998-05-07 Farmigea Spa Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo
US5800807A (en) 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol
US6261547B1 (en) 1998-04-07 2001-07-17 Alcon Manufacturing, Ltd. Gelling ophthalmic compositions containing xanthan gum
US6197934B1 (en) 1998-05-22 2001-03-06 Collagenesis, Inc. Compound delivery using rapidly dissolving collagen film
EP2086546B1 (en) * 2006-11-21 2013-07-10 Viamet Pharmaceuticals, Inc. Metallo-oxidoreductase inhibitors using metal binding moieties in combination with targeting moieties
WO2008124131A1 (en) * 2007-04-05 2008-10-16 The John Hopkins University Antifungal agents as neuroprotectants
CA2837400C (en) * 2010-04-24 2017-12-12 Viamet Pharmaceuticals, Inc. 5-(optionally substituted phenyl) pyridin-2-yl compounds as metalloenzyme inhibitors
EP2721023B1 (en) * 2011-06-19 2018-08-08 Viamet Pharmaceuticals (NC), Inc. Metalloenzyme inhibitor compounds
JP6122846B2 (ja) * 2011-06-19 2017-04-26 ヴィアメット ファーマスーティカルズ，インコーポレイテッド 金属酵素阻害剤化合物

Also Published As

Publication number Publication date
ZA201400232B (en) 2015-06-24
CA2838912A1 (en) 2012-12-27
CN103781775B (zh) 2016-11-16
CR20140020A (es) 2014-07-02
US20130005752A1 (en) 2013-01-03
EP3067350B1 (en) 2018-06-13
JP2014517068A (ja) 2014-07-17
EP3398944A1 (en) 2018-11-07
EP2721023A1 (en) 2014-04-23
AU2012273103A1 (en) 2014-01-23
BR102012015179A2 (pt) 2014-04-22
BR102012015179B1 (pt) 2021-09-14
KR20180095108A (ko) 2018-08-24
JP2017132766A (ja) 2017-08-03
EA024789B1 (ru) 2016-10-31
US20140288107A1 (en) 2014-09-25
CA2838912C (en) 2019-11-26
EA201490029A1 (ru) 2014-11-28
AU2012273103B2 (en) 2017-04-20
UY39413A (es) 2021-10-29
AR088130A1 (es) 2014-05-14
JP2014518220A (ja) 2014-07-28
KR20180095109A (ko) 2018-08-24
AU2012273100B2 (en) 2017-05-25
EA025406B1 (ru) 2016-12-30
EP2721023A4 (en) 2014-11-26
US8748461B2 (en) 2014-06-10
US8796001B2 (en) 2014-08-05
CA2839691A1 (en) 2012-12-27
US20120329788A1 (en) 2012-12-27
CN103764647A (zh) 2014-04-30
UY34145A (es) 2013-01-31
CN105884743A (zh) 2016-08-24
AU2012273100A1 (en) 2014-01-16
ES2700250T3 (es) 2019-02-14
MX351943B (es) 2017-11-03
EP2721022A1 (en) 2014-04-23
CL2013003638A1 (es) 2014-10-10
JP6247632B2 (ja) 2017-12-13
ECSP22051489A (es) 2022-07-29
EP2721022B1 (en) 2019-03-06
IL229965A (en) 2016-06-30
CN103781775A (zh) 2014-05-07
UA114090C2 (uk) 2017-04-25
ECSP14013152A (es) 2014-04-30
EP3067350A1 (en) 2016-09-14
CO6930356A2 (es) 2014-04-28
MX2013015158A (es) 2014-12-05
KR20140040237A (ko) 2014-04-02
CN103764647B (zh) 2016-05-18
JP6158797B2 (ja) 2017-07-05
EP2721022A4 (en) 2014-11-26
US9220265B2 (en) 2015-12-29
KR20140040236A (ko) 2014-04-02
IN2014DN00288A (ru) 2015-06-05
KR101912844B1 (ko) 2018-10-30
HK1198163A1 (en) 2015-03-13
BR122020013521B1 (pt) 2021-05-25
KR101912848B1 (ko) 2018-10-30
WO2012177635A1 (en) 2012-12-27
WO2012177638A1 (en) 2012-12-27
CN105884743B (zh) 2019-08-06
EP2721023B1 (en) 2018-08-08

Similar Documents

Publication Publication Date Title
EA201490030A1 (ru) Соединения, ингибирующие металлоферменты
CY1120246T1 (el) Ενωσεις αναστολεων μεταλλοενζυμου
EA201690007A1 (ru) Соединения, ингибирующие металлоферменты
EA201891539A1 (ru) Соединения, ингибирующие металлоферменты
EA201490052A1 (ru) Соединения, ингибирующие металлоферменты
EA201490038A1 (ru) Соединения, ингибирующие металлоферменты
EA201291107A1 (ru) Соединения, ингибирующие металлоферменты
EA201491385A1 (ru) Соединения, ингибирующие металлоферменты
EA201390704A1 (ru) Соединения, ингибирующие металлоферменты
EA201691121A1 (ru) Гидроксиамидные соединения пиримидина в качестве ингибиторов деацетилаз белков и способы их применения
EA201270100A1 (ru) Пиримидиноны в качестве ингибиторов pi3k
WO2011082245A3 (en) Metalloenzyme inhibitor compounds
UY36080A (es) Compuestos inhibidores de metaloenzima como fungicidas.
MX2022012386A (es) Compuestos inhibidores de metaloenzimas.
WO2012058529A3 (en) Metalloenzyme inhibitor compounds
UY36081A (es) Compuestos inhibidores de metaloenzima como fungicidas.
EA201390876A1 (ru) Соединения, ингибирующие металлоферменты
WO2018125799A3 (en) Metalloenzyme inhibitor compounds
WO2013033004A3 (en) Metalloenzyme inhibitor compounds

Legal Events

Date Code Title Description
TC4A Change in name of a patent proprietor in a eurasian patent